Skip to main content
Equibles

ALLIANCEBERNSTEIN L.P.

Position in VCEL — Vericel Corp

CIK 1109448 NASHVILLE, TN
Back to VCEL Full portfolio

Position in VCEL

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$3,365,757
+$1,456,404 QoQ
Shares Held
75,652
+27.5% QoQ
Ownership
0.148%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#81
of 317 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 90% Shared 0% None 10%

Common Shares in VCEL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ALLIANCEBERNSTEIN L.P. holds $5,185,395,108 across 257 Biotechnology names. VCEL ranks #81 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,019,315 $1,499,784,339
2 ARGX
Argenx SE
 395,661 $367,082,405
3 GMAB
Genmab A/S
 8,644,877 $237,474,771
4 REGN
Regeneron Pharmaceuticals, Inc.
 292,338 $182,284,436
5 TECH
BIO-TECHNE Corp
 2,002,026 $141,443,136
6 HALO
Halozyme Therapeutics, Inc.
 1,696,538 $132,788,029
7 KYMR
Kymera Therapeutics, Inc.
 981,521 $112,551,013
8 BBIO
BridgeBio Pharma, Inc.
 1,453,504 $108,256,977

All Filings in VCEL

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,365,757 75,652
2026-03-31 $1,909,353 59,352
2025-12-31 $2,111,662 58,641
2025-09-30 $1,648,272 52,376
2025-06-30 $2,225,365 52,300
2025-03-31 $2,442,454 54,739
2024-12-31 $3,005,224 54,730
2024-09-30 $2,445,852 57,890
2024-06-30 $2,657,140 57,915
2024-03-31 $3,012,738 57,915
2023-12-31 $1,928,993 54,170
2023-09-30 $1,806,728 53,900
2023-06-30 $4,142,843 110,270
2023-03-31 $3,294,102 112,350
2022-12-31 $3,142,862 119,319
2022-09-30 $2,767,087 119,271
2022-06-30 $2,537,665 100,781
2022-03-31 $3,809,463 99,672
2021-12-31 $3,910,585 99,506
2021-09-30 $4,849,744 99,380
2021-06-30 $5,374,950 102,380
2021-03-31 $3,263,562 58,750
2020-12-31 $1,763,248 57,100
2020-09-30 $1,058,063 57,100
2020-06-30 $789,122 57,100
2020-03-31 $523,607 57,100